The University of Southampton
University of Southampton Institutional Repository

Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalised human B-cell line GM607 but do not confer tumourigenicity

Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalised human B-cell line GM607 but do not confer tumourigenicity
Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalised human B-cell line GM607 but do not confer tumourigenicity
Eighty-five percent of follicular lymphomas (FL) possess a characteristic t(14;18) translocation that results in the deregulated expression of the proto-oncogene BCL-2. BCL-2 overexpression alone is insufficient for full cellular transformation and at least one other genetic event is believed to be necessary for FL development. Deregulated c-Myc expression has previously been shown to co-operate with Bcl-2 to transform murine fibroblast cell lines and lead to tumor development in mice. We have developed a human model system to study early transformation in lymphoid cells using immortalised lymphoblastoid cells. We sequentially introduced BCL-2 and c-MYC, two proto-oncogenes known to be involved in the transformation of B-cells into EBV immortalised human B cells. We show that the c-Myc and Bcl-2 overexpression, together with EBV immortalization were insufficient to cause full cellular transformation as measured by cell proliferation rates, soft agar and tumourigenicity assays. These results show that more than three genetic hits (EBV infection, BCL-2 and c-MYC overexpression) were required for the full cellular transformation of human lymphoblastoid cells. However, subtle changes in cellular proliferation and sensitivity to apoptosis were documented, at non-limiting dilutions. These changes may confer a susceptibility to the modified cells such that they are more susceptible to the acquisition of additional genetic changes and evolve towards a fully transformed state. In addition, the model system developed may be suitable for the identification of further known and novel oncogenic events involved in the full transformation of B-cells
Bcl-2, c-Myc, lymphoma, apoptosis, transformation
1042-8194
581-592
Tomlin, Jennifer L.
ccd970de-752b-414e-aba5-1c85adf8bc0d
Guinn, Barbara-Ann
728d28c9-a23d-413a-ba1d-4531005705d7
Penn, Linda Z.
a68d57c5-360b-41f3-9fa0-42a6c5c78801
Berinstein, Neil L.
7bdb1cdc-f5e4-4e45-b08a-220de9789a17
Tomlin, Jennifer L.
ccd970de-752b-414e-aba5-1c85adf8bc0d
Guinn, Barbara-Ann
728d28c9-a23d-413a-ba1d-4531005705d7
Penn, Linda Z.
a68d57c5-360b-41f3-9fa0-42a6c5c78801
Berinstein, Neil L.
7bdb1cdc-f5e4-4e45-b08a-220de9789a17

Tomlin, Jennifer L., Guinn, Barbara-Ann, Penn, Linda Z. and Berinstein, Neil L. (2005) Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalised human B-cell line GM607 but do not confer tumourigenicity. Leukemia and Lymphoma, 46 (4), 581-592. (doi:10.1080/10428190400019867).

Record type: Article

Abstract

Eighty-five percent of follicular lymphomas (FL) possess a characteristic t(14;18) translocation that results in the deregulated expression of the proto-oncogene BCL-2. BCL-2 overexpression alone is insufficient for full cellular transformation and at least one other genetic event is believed to be necessary for FL development. Deregulated c-Myc expression has previously been shown to co-operate with Bcl-2 to transform murine fibroblast cell lines and lead to tumor development in mice. We have developed a human model system to study early transformation in lymphoid cells using immortalised lymphoblastoid cells. We sequentially introduced BCL-2 and c-MYC, two proto-oncogenes known to be involved in the transformation of B-cells into EBV immortalised human B cells. We show that the c-Myc and Bcl-2 overexpression, together with EBV immortalization were insufficient to cause full cellular transformation as measured by cell proliferation rates, soft agar and tumourigenicity assays. These results show that more than three genetic hits (EBV infection, BCL-2 and c-MYC overexpression) were required for the full cellular transformation of human lymphoblastoid cells. However, subtle changes in cellular proliferation and sensitivity to apoptosis were documented, at non-limiting dilutions. These changes may confer a susceptibility to the modified cells such that they are more susceptible to the acquisition of additional genetic changes and evolve towards a fully transformed state. In addition, the model system developed may be suitable for the identification of further known and novel oncogenic events involved in the full transformation of B-cells

This record has no associated files available for download.

More information

Submitted date: April 2005
Published date: April 2005
Keywords: Bcl-2, c-Myc, lymphoma, apoptosis, transformation

Identifiers

Local EPrints ID: 71576
URI: http://eprints.soton.ac.uk/id/eprint/71576
ISSN: 1042-8194
PURE UUID: ace9d36e-5c28-4f25-a679-1217b99777d4

Catalogue record

Date deposited: 14 Dec 2009
Last modified: 13 Mar 2024 20:33

Export record

Altmetrics

Contributors

Author: Jennifer L. Tomlin
Author: Barbara-Ann Guinn
Author: Linda Z. Penn
Author: Neil L. Berinstein

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×